Clinical Trials

Consumer-Based Meditation App, Calm, for Treatment of Sleep Disturbance in Hematological Cancer Patients (CTMS# 22-0116)

Cancer Type

Acute Lymphoblasic Leukemia, Leukemia, other, Lymphoid Leukemia, Lymphoma, Myeloma, Acute Myeloid Leukemia, Other Hematopoietic, Myeloid and Monocytic Leukemia, Multiple Myeloma, Hematological Malignancy

ClinicalTrials.gov Identifier

ClinicalTrials.gov registration not required

For more information about this study
View Details

About This Study

Are you undergoing treatment for a blood cancer diagnosis and experiencing poor sleep?Researchers at the Mays Cancer Center are seeking US-based adults diagnosed with blood cancer and experiencing sleep disturbance to participate in a 20-week remote study testing a digital wellness intervention. Participants in this study will be assigned to use one of two digital wellness apps 10 minutes per day over 8-weeks to determine if it can help improve sleep, immune function, and other psychological and emotional outcomes.This study is completely remote (there are no in-person visits with the research team) and patients from across the USA are invited.Participation involves:One brief 30-minute virtual meeting with a research assistantCompleting online surveysProviding three blood samples over the 20-week study at a lab close to youTracking sleep using a small device and daily diaryUsing a wellness app for 10 minutes per day for 8-weeksParticipants who qualify and are enrolled in the study will be compensated at regular intervals, up to $100 total.